What is the NOAEL for Thorium(IV) oxide?
Thorium(IV) oxide has 8 NOAEL studies in the database. The lowest reported value is cancer listing type. Source: California Proposition 65.
Also known as: EINECS 215-225-1, Thorianite, Thorium anhydride, Thortrast, Thorium-232 dioxide (+3 more)
CAS 1314-20-1
Thorium(IV) oxide (CAS 1314-20-1) is a chemical substance; key hazard signal: cancer. Key regulatory status: California Proposition 65, 2 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, CA Prop 65, EPA TRI.
Thorium(IV) oxide is prohibited in EU cosmetics but has active industrial GHS classifications (H301, H311, H331, H350, H373).
CAS, identifiers, formula, and alternate names for the matched substance record.
California OEHHA listing status and toxicity category.
| Chemical | Toxicity Type | Cancer | Developmental | Listed |
|---|---|---|---|---|
| - | cancer | Yes | No | - |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| OEHHA Proposition 65 (3/2019) | STATE OF CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY | OEHHA Proposition 65 List |
| OEHHA Proposition 65 (1/2023) | California Office of Environmental Health Hazard Assessment | OEHHA Proposition 65 List |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| LCcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| LCcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| LCcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| LCcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| 9XA7X17UQC | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 9XA7X17UQC | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 9XA7X17UQC | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 9XA7X17UQC | UNII | FDA UNII substance identifier | - | - | openFDA substances |
Showing 8 of 8 studies
TRI hazard and reporting flags for the matched chemical.
| Chemical | Category | Flags |
|---|---|---|
| Thorium dioxide | - | - |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Thorium(IV) oxide has 8 NOAEL studies in the database. The lowest reported value is cancer listing type. Source: California Proposition 65.
Thorium(IV) oxide appears on 2 regulatory/inventory lists including OEHHA Proposition 65 (3/2019), OEHHA Proposition 65 (1/2023). Source: EPA CPDat.
Yes, Thorium(IV) oxide is listed under California Proposition 65 for cancer. Source: California OEHHA Proposition 65.
Yes, Thorium(IV) oxide is also indexed as a cosmetic ingredient under the name Thorium Dioxide. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, California Proposition 65, EPA Toxics Release Inventory, CosIng / Ingredients DB. All data traces to primary regulatory sources and is updated from official government databases.
Thorium(IV) oxide is prohibited in EU cosmetics but has active industrial GHS classifications (H301, H311, H331, H350, H373).
Thorium(IV) oxide also appears in cosmetics databases.